DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
7.39
-0.09 (-1.20%)
Aug 13, 2026, 1:09 PM EDT - Market open

DarioHealth Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2122.3627.0420.3527.6620.51
Revenue Growth
-22.65%-17.31%32.86%-26.41%34.82%170.76%
Cost of Revenue
8.799.6913.7714.371816.55
Gross Profit
12.2112.6713.275.989.663.96
Selling, General & Admin
33.635.5346.8341.9346.8263.24
Research & Development
10.4513.7924.1820.2519.6517.22
Total Operating Expenses
44.0549.3271.0162.1766.4780.46
Operating Income
-31.83-36.66-57.74-56.19-56.81-76.49
Total Non-Operating Income (Expense)
-3.37-4.9513.15-3.17-5.38-0.24
Pretax Income
-35.2-41.61-44.6-59.36-62.19-76.73
Provision for Income Taxes
0.470.11-1.850.0600.03
Net Income
-35.67-41.71-42.75-59.43-62.19-76.76
Net Income Attributable to Preferred Dividends
9.6120.02-1.774.081.642.01
Net Income to Common
-45.28-61.74-40.98-63.51-63.84-78.77
Net Income Growth
------
Shares Outstanding (Basic)
742111
Shares Outstanding (Diluted)
742111
Shares Change
149.42%62.44%80.35%15.05%42.45%178.23%
EPS (Basic)
-6.13-10.12-12.27-46.71-50.80-81.40
EPS (Diluted)
-6.13-10.12-12.27-46.71-50.80-81.40
EPS Growth
------
Free Cash Flow
-25.48-26.08-38.7-30.96-48.29-50.67
Free Cash Flow Growth
------
Free Cash Flow Per Share
-3.78-6.55-15.78-22.77-40.86-61.08
Gross Margin
58.15%56.64%49.06%29.40%34.91%19.32%
Operating Margin
-151.60%-163.94%-213.55%-276.09%-205.42%-372.90%
Profit Margin
-169.87%-186.56%-158.09%-292.00%-224.88%-374.21%
FCF Margin
-121.34%-116.66%-143.12%-152.14%-174.60%-247.01%
EBITDA
-29.72-33.52-50.32-51.2-52.09-72.04
EBITDA Margin
-141.51%-149.90%-186.08%-251.59%-188.36%-351.18%
EBIT
-31.83-36.66-57.74-56.19-56.81-76.49
EBIT Margin
-151.60%-163.94%-213.55%-276.09%-205.42%-372.90%
Effective Tax Rate
-1.33%-0.25%4.15%-0.11%-0.01%-0.04%
SEC Filings: 10-K · 10-Q